eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | acromegaly |
| Comorbidity | C0032000|pituitary adenoma |
| Sentences | 8 |
| PubMedID- 26071586 | Objective: to determine immunohistochemical expression of eag1 in pituitary adenomas of patients with acromegaly and to assess the correlation between eag1 expression with cavernous sinus invasion, tumoral ki-67 labeling index (li), age and gender of the patients. |
| PubMedID- 24101276 | acromegaly associated with mixed pituitary adenoma-gangliocytoma and rathke's cleft cyst. |
| PubMedID- 21597975 | Determined costs for 11 acromegaly patients with invasive pituitary adenomas [59]. |
| PubMedID- 22029034 | acromegaly with no pituitary adenoma and no evidence of ectopic source. |
| PubMedID- 23512282 | We conclude from this case and a literature review that double endocrinologically active pituitary adenomas leading to acromegaly and cushing's disease may occur. |
| PubMedID- 24447924 | It is characterized by cm, extracardiac myxomas (mucosal and cutaneous), osteochondromyxoma, spotty skin pigmentation, myxomatous tumors of the breast, ductal adenoma of breast, blue nevi, endocrine overactivity and tumors (hypercortisolism, pituitary adenoma with acromegaly or gigantism, thyroid tumors, testicular large cell calcifying sertoli cell tumors (lccst) and psammomatous melanotic schwannoma (pms)) and paradoxical positive response of urinary glucocorticoids to dexamethasone administration (ppnad) during liddle’s test [22,23]. |
| PubMedID- 21744088 | Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: sstr5 polymorphism and pkd1 mutation. |
| PubMedID- 24239736 | Objective: this study sought to characterize the utility of coregistered 11c-methionine positron emission tomography (met-pet) with 3-t magnetic resonance imaging (3t mri) in the diagnosis and follow-up of pituitary adenomas in patients with acromegaly and to compare met-pet and 18f-fluorodeoxyglucose emission tomography (fdg-pet) for the evaluation of active or recurrent disease. |
Page: 1